GLOFITAMAB for Mantle cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 60 adverse event reports in the FDA FAERS database where GLOFITAMAB was used for Mantle cell lymphoma.
Most Reported Side Effects for GLOFITAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 415 | 37.2% | 102 | 239 |
| Disease progression | 183 | 16.4% | 78 | 39 |
| Off label use | 129 | 11.6% | 37 | 44 |
| Death | 125 | 11.2% | 125 | 12 |
| Neutropenia | 109 | 9.8% | 18 | 59 |
| Pyrexia | 78 | 7.0% | 15 | 46 |
| Febrile neutropenia | 69 | 6.2% | 2 | 55 |
| Covid-19 | 62 | 5.6% | 11 | 31 |
| Drug ineffective | 53 | 4.8% | 10 | 10 |
| Immune effector cell-associated neurotoxicity syndrome | 45 | 4.0% | 17 | 16 |
| Infection | 44 | 3.9% | 28 | 12 |
| Pneumonia | 41 | 3.7% | 11 | 20 |
| Sepsis | 29 | 2.6% | 15 | 14 |
| Septic shock | 27 | 2.4% | 20 | 15 |
| Alanine aminotransferase increased | 26 | 2.3% | 2 | 15 |
Other Indications for GLOFITAMAB
Diffuse large b-cell lymphoma (535)
Product used for unknown indication (107)
B-cell lymphoma (95)
Diffuse large b-cell lymphoma refractory (55)
Non-hodgkin's lymphoma (44)
Diffuse large b-cell lymphoma stage iv (38)
Follicular lymphoma (29)
B-cell lymphoma refractory (27)
Richter's syndrome (24)
Lymphoma transformation (19)
Other Drugs Used for Mantle cell lymphoma
IBRUTINIB (6,306)
RITUXIMAB (3,940)
LENALIDOMIDE (2,989)
CYCLOPHOSPHAMIDE (1,815)
DOXORUBICIN (1,396)
VENETOCLAX (1,367)
VINCRISTINE (1,361)
BENDAMUSTINE (1,227)
CYTARABINE (1,174)
DEXAMETHASONE (949)